Keraplast Technologies
markets Functional Keratin® ingredients across personal care, nutraceuticals and wound care, including keraGEN-IV®, an ingestible keratin-derived peptide product for hair, skin and nail health, alongside its keratin-based wound-care lines.
- Country
- United States
wound-care
us
Coverage
| CN | EU | US | |
|---|---|---|---|
| fibers-textiles | ✓ | ✓ | ✓ |
Regulatorsfdareachnmpa
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Keratin-based materials | fibers-textiles | Medium | → |
Compiled by BIOECON via the bioecon-brief pipeline.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.